Filtering options
Advanced Analytics
Agreement Studies
Bayesian Design
Biologics
Biometrics
Biostatistics
Biotech
Bordeaux
Business Strategy
CDMO
Clinical
Clinical Operations
Clinical Trial Management
Clinical Trials
CMC
Contract Development and Manufacturing
CRO
Crowdfunding
Data Science
Data Specialist
Decentralized Clinical Trials
Dermatology
Diagnotics
Digital Health
Digital Therapeutics
Digital Transformation
Diversity
DPHARM
Drug Development
DTx
DTx trends
Due Diligence
eCOA
European Medicines Agency
France
Genomic Testing
Healthcare Technology
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Inclusion
Investor Relations
IVDR
Life Sciences
M&A
Market Access
Medical Devices
Medical Robotics
MedTech
Mobile Tech
Orphan Drug
Outsourcing Clinical Trials
Patient Advocacy
Patient Centric
Patient Centricity
Patient Engagement
Pharma
Product Development
Rare Disease
Rare Disease Trials
Real-World Evidence
Registry-based studies
Regulatory
Research & Development
Research and Development
Robotcs
RWE
Startups
Therapeutics
Vaccines
All
Events
Latest from Alira Health
Regulatory Strategy for Registering Rare Disease Products in the EU
In this webinar we will focus on how to benefit, today and in the future, from the orphan drug program and build a regulatory strategy for successful rare disease product registration(...)
HealthBiz Podcast: Interview with Gabriele Brambilla
Gabriele Brambilla, CEO of Alira Health, has joined the HealthBiz podcast to discuss how Alira Health strives to achieve its mission of humanizing healthcare, the importance of seeing(...)
Business Strategy and Go-to-Market in Medical Robotics
We are pleased to announce that on September 27 we will co-host an online workshop “Business Strategy and Go-to-Market in Medical Robotics” with The Hamlyn Centre for Robotic Surgery.
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.
Alira Health and Legit.Health Partner to Empower Patients in Dermatology Clinical Research
Alira Health digital health solutions combined with Legit.Health’s AI-driven image assessment tool offer a unique platform for dermatology DCT, RWE and DTx.
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Critical Quality Attributes for Drug Products
In this article, we will explore the importance of Critical Quality Attributes (CQAs) in the drug development lifecycle and why it is vital that your selected CDMO is capable of addressing them.
Best Practices in the CDMO Selection Process
The CDMO series provides sound advice to agile biotech companies in identifying and selecting the right Contract Development and Manufacturing Organization (CDMO) for advancing the(...)
Subscribe to our newsletter for the latest news, events, and thought leadership